Bio-Rad Laboratories (BIO-B) Current Assets (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Current Assets data on file, last reported at $2.9 billion in Q1 2026.

• Current Assets for Q1 2026 came in at $2.9 billion, down 3.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 billion (down 3.11% YoY), and the FY2025 annual result was $2.9 billion, down 4.1% from the prior year.
• Current Assets rose to $2.9 billion in Q1 2026 per BIO-B's latest filing, from $2.9 billion in the prior quarter.
• Over five years, Current Assets peaked at $3.3 billion in Q1 2022 and troughed at $2.8 billion in Q2 2025.
• A 5-year average of $3.1 billion and a median of $3.1 billion in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2025: Current Assets soared 58.65% in 2022, then fell 8.02% in 2025.
• A 5-year view of Current Assets shows it stood at $3.2 billion in 2022, then retreated by 3.47% to $3.0 billion in 2023, then retreated by 0.59% to $3.0 billion in 2024, then slipped by 4.1% to $2.9 billion in 2025, then increased by 1.24% to $2.9 billion in 2026.
• Business Quant data shows BIO-B's Current Assets at $2.9 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.8 billion in Q3 2025.